Moneco Advisors, LLC Gilead Sciences, Inc. Transaction History

Moneco Advisors, LLC

$667 Million
Q2 2024

A detailed history of Moneco Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moneco Advisors, LLC holds 6,266 shares of GILD stock, worth $527,409. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,266

Previous 6,141 2.04%

Holding current value

$527,409

Previous $449,000 4.45%

% of portfolio

0.06%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$63.15 - $72.88 $7,893 - $9,110	125 Added 2.04%	6,266 $429,000
Q1 2024 Apr 25, 2024	SELL	$71.58 - $87.29 $12,598 - $15,363	-176 Reduced 2.79%	6,141 $449,000
Q4 2023 Mar 13, 2024	BUY	$73.27 - $83.09 $50,629 - $57,415	691 Added 12.28%	6,317 $511,000
Q4 2023 Feb 05, 2024	BUY	$73.27 - $83.09 $50,409 - $57,165	688 Added 12.24%	6,307 $510,000
Q3 2023 Mar 13, 2024	BUY	$73.94 - $80.67 $41,258 - $45,013	558 Added 11.01%	5,626 $421,000
Q3 2023 Nov 03, 2023	BUY	$73.94 - $80.67 $41,036 - $44,771	555 Added 10.96%	5,619 $421,000
Q2 2023 Mar 13, 2024	SELL	$76.01 - $86.7 $94,176 - $107,421	-1,239 Reduced 19.64%	5,068 $390,000
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $17,330 - $19,767	228 Added 4.71%	5,064 $390,000
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $64,399 - $73,370	833 Added 20.81%	4,836 $401,000
Q4 2022 Jan 27, 2023	BUY	$62.32 - $89.47 $15,704 - $22,546	252 Added 6.72%	4,003 $343,000
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $223,334 - $255,105	3,751 New	3,751 $231,000
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $192,953 - $219,005	-2,974 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $25,519 - $27,532	-377 Reduced 11.25%	2,974 $208,000
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $212,687 - $232,391	3,351 New	3,351 $231,000
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $163,447 - $205,506	-2,632 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $190,398 - $221,088	2,632 New	2,632 $203,000

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneco Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneco Advisors, LLC with notifications on news.

Account

Moneco Advisors, LLC Gilead Sciences, Inc. Transaction History